Presented by Nariman Nasser, Director of CTSI's Participant Recruitment Service, at the SCOPE (Summit for Clinical Ops Executives) Conference in Miami, Feb 2012.
Infographic- Improve Clinical Trial Participation with Mobile AppsDiaspark
Mobile apps are pivotal to patient recruitment & retention in clinical trials, we have done research on changing trends &d challenges in clinical trial patient recruitment & retention.
The Elite Research Network is a network of 28 clinical research sites in the United States and 2 in Latin America with over 450,000 patients in their database. The network focuses on pediatric, adolescent, adult and elderly patient populations. The independently owned sites have dedicated staff for regulatory, quality assurance, and contracting/budgeting functions and can start regulatory documents within 5 days. The network has experience conducting over 4,000 studies across many therapeutic areas over the last 4 years.
This document summarizes the key findings from stakeholder meetings on developing recommendations for transparently reporting data quality assessment results for observational healthcare data. Stakeholders highlighted the implications of poor data quality, barriers to conducting and reporting assessments, and interest in involving patients and policymakers. A framework was created with 20 recommendations for systematically reporting on data quality and describing stewardship efforts to address growing use of electronic healthcare data from multiple sources.
Technician Education and Training in the Dialysis IndustrySteve Davis
Demand for dialysis treatment in the United States has exploded over the past few decades due to the rising prevalence of poor dietary and exercise behaviors. Diseases such as obesity, diabetes, and high blood pressure have had devastating effects on the health and well-being of the public and have led to the creation of hundreds of new dialysis treatment facilities. In order to provide comprehensive and accessible care, administrators have started recruiting thousands of new technicians to perform routine patient care activities. This has resulted in many new employment opportunities for unlicensed allied health personnel who are looking for a career path that has relatively few barriers to entry. Those who choose to pursue this profession can complete their education and training through either an in-house program offered by the employer or through an independent educational institution such as a community college or vocational school that administers a certificate option specific to the specialty. After training has been completed, the technician will typically be required to pass a national certification examination.
The document summarizes the ID-Web Project which aims to improve care and surveillance of infectious diseases like HIV, STDs, and hepatitis B among American Indian/Alaskan Native populations. It does this by providing clinical staff at 5 pilot sites feedback on key caseload and care indicators through a web-based system linked to training on national guidelines. Preliminary results suggest the system demonstrates a potentially powerful tool to help providers deliver high quality care and could be expanded to include other infectious diseases with larger scale implementation dependent on support of data entry and perceived value.
CancerLinQ aims to harness big data to improve cancer care by learning from every patient. It faces challenges of integrating diverse data types from genomics to behaviors. Its goals are precision, personalized medicine through molecular profiling of individual cancers. As clinical trials enroll few patients, CancerLinQ would provide real-world data from electronic health records to uncover new insights. When deployed, it will analyze de-identified patient records to uncover care patterns, allow comparing care to guidelines and peers, and provide evidence-based guidance. This has the potential to improve outcomes for patients and quality for providers and researchers.
This document provides information about an upcoming conference on oncology endpoints and quality of life assessments taking place in November 2015 in Philadelphia. Attendees will learn about (1) selecting clinical trial endpoints and interpreting quality of life measures to satisfy regulatory requirements, (2) understanding patient needs when designing trials and assessing oncology endpoints, and (3) developing patient-reported outcome tools to evaluate the benefits and risks of treatments. Featured speakers will provide insights and case studies on rapidly changing practices for endpoint selection and validation in oncology trials.
Infographic- Improve Clinical Trial Participation with Mobile AppsDiaspark
Mobile apps are pivotal to patient recruitment & retention in clinical trials, we have done research on changing trends &d challenges in clinical trial patient recruitment & retention.
The Elite Research Network is a network of 28 clinical research sites in the United States and 2 in Latin America with over 450,000 patients in their database. The network focuses on pediatric, adolescent, adult and elderly patient populations. The independently owned sites have dedicated staff for regulatory, quality assurance, and contracting/budgeting functions and can start regulatory documents within 5 days. The network has experience conducting over 4,000 studies across many therapeutic areas over the last 4 years.
This document summarizes the key findings from stakeholder meetings on developing recommendations for transparently reporting data quality assessment results for observational healthcare data. Stakeholders highlighted the implications of poor data quality, barriers to conducting and reporting assessments, and interest in involving patients and policymakers. A framework was created with 20 recommendations for systematically reporting on data quality and describing stewardship efforts to address growing use of electronic healthcare data from multiple sources.
Technician Education and Training in the Dialysis IndustrySteve Davis
Demand for dialysis treatment in the United States has exploded over the past few decades due to the rising prevalence of poor dietary and exercise behaviors. Diseases such as obesity, diabetes, and high blood pressure have had devastating effects on the health and well-being of the public and have led to the creation of hundreds of new dialysis treatment facilities. In order to provide comprehensive and accessible care, administrators have started recruiting thousands of new technicians to perform routine patient care activities. This has resulted in many new employment opportunities for unlicensed allied health personnel who are looking for a career path that has relatively few barriers to entry. Those who choose to pursue this profession can complete their education and training through either an in-house program offered by the employer or through an independent educational institution such as a community college or vocational school that administers a certificate option specific to the specialty. After training has been completed, the technician will typically be required to pass a national certification examination.
The document summarizes the ID-Web Project which aims to improve care and surveillance of infectious diseases like HIV, STDs, and hepatitis B among American Indian/Alaskan Native populations. It does this by providing clinical staff at 5 pilot sites feedback on key caseload and care indicators through a web-based system linked to training on national guidelines. Preliminary results suggest the system demonstrates a potentially powerful tool to help providers deliver high quality care and could be expanded to include other infectious diseases with larger scale implementation dependent on support of data entry and perceived value.
CancerLinQ aims to harness big data to improve cancer care by learning from every patient. It faces challenges of integrating diverse data types from genomics to behaviors. Its goals are precision, personalized medicine through molecular profiling of individual cancers. As clinical trials enroll few patients, CancerLinQ would provide real-world data from electronic health records to uncover new insights. When deployed, it will analyze de-identified patient records to uncover care patterns, allow comparing care to guidelines and peers, and provide evidence-based guidance. This has the potential to improve outcomes for patients and quality for providers and researchers.
This document provides information about an upcoming conference on oncology endpoints and quality of life assessments taking place in November 2015 in Philadelphia. Attendees will learn about (1) selecting clinical trial endpoints and interpreting quality of life measures to satisfy regulatory requirements, (2) understanding patient needs when designing trials and assessing oncology endpoints, and (3) developing patient-reported outcome tools to evaluate the benefits and risks of treatments. Featured speakers will provide insights and case studies on rapidly changing practices for endpoint selection and validation in oncology trials.
Primary care-based, teleretinal-screening protocol (Los Angeles Safety Net) UCLA CTSI
UCLA CTSI-Los Angeles County Department of Health Services (DHS) Projects
Principal Investigators: Lauren Daskivich (DHS), Carol Mangione (UCLA)
Diabetic retinopathy (DR) is the leading cause of blindness among working-age Americans, and among Los Angeles Latinos—the ethnic majority of patients in the Los Angeles County (LAC) safety net—the prevalence of DR is ~50%. Despite evidence that early detection and treatment can prevent blindness from DR, a significant number of persons with diabetes in our system fail to receive annual screening examinations and/or sight-saving treatments due to lack of access to specialty care. To date, the effect of a system level intervention on improving access to eye care and definitive treatment for diabetic retinopathy in an urban medically underserved, or safety net, population has not been evaluated. The objective of this project is to evaluate the impact of teleretinal screening on access to specialty ophthalmic care for diabetic patients in LAC who need monitoring or treatment for diabetic retinopathy. We propose a pre-post analysis of the LAC teleretinal screening implementation, and we aim to evaluate the number of patients screened for diabetic retinopathy, the number presenting for timely ophthalmic follow-up care and treatment, and the cost of the program.
This document discusses the development of a chronic disease diagnosis (CDD) system using large datasets to predict disease risk and provide medical advice recommendations. Currently, a hybrid CDD method uses multiple classification algorithms and collaborative filtering to build an accurate predictive model. Testing of the CDD system is being done using Middle Eastern data and future work involves further testing using diabetes case studies to improve accuracy and feasibility of recommendations.
SITIST 2015 Dev - Turning big data into presicion medicine real life examplessitist
Big data in healthcare comes from a variety of sources and formats including clinical trials, patient records, medical literature, genomic data, and medical imaging. This large volume of data presents challenges to make it accessible and usable. SAP offers platforms and solutions to unlock the value in healthcare big data by enabling precision medicine through analyzing diverse clinical and genomic data sources. Examples include SAP's partnership with ASCO on the CancerLinQ project to link oncology data and improve cancer treatment, and SAP Medical Research Insights deployed at the National Center for Tumor Diseases in Heidelberg, Germany.
This document discusses an integrated clinical engagement model for personal health records (PHRs). It describes key drivers for this model including efforts to increase efficiency, wellness, medical management, and consumer experience. The model includes a clinical data repository that integrates various types of patient data. Challenges include a lack of standards for transferring all types of PHR data between health plans and representing elements such as alerts and physiological information. Alignment with existing standards and expanding PHR data domains are suggested for moving forward.
Information technology, Transformational change - Stories from the road. Presented by Robyn Cook, IT Project Manager, University of New South Wales, Australia, at HINZ 2014, 12 November 2014, 1.45pm, Marlborough Room
This document discusses strategies for improving timely access to healthcare services in Alberta, Canada. It proposes standardizing referral processes, automating referral tracking, and using clinical decision support tools. An online referral system called Netcare has launched for several specialties, with mixed results. Next steps include continued support and evaluation of the system with the goal of broader adoption and improved wait times.
A project with the aim to standardize an RBM approach in clinical trials. It unites four companies and academic organizations, focuses on the evaluation and optimization of Risk-based Monitoring (RbM). For this purpose, PUEKS will use data available from past clinical studies to select substantiated key risk indicators (KRIs). Subsequently, the obtained data-driven KRIs will be tested in an ongoing trial. A comparative evaluation with historical data from past studies will be additionally performed to evaluate the power of the selected KRIs in terms of cost savings, enhanced quality, and risk mitigation. The project is aimed at delivering a robust RbM tool as well as an optimized procedure for the successful implementation of RbM.
This project (HA project no. 448/14-38) is funded in the framework of Hessen ModellProjekte, financed with funds of LOEWE – Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Förderlinie 3: KMU-Verbundvorhaben (State Offensive for the Development of Scientific and Economic Excellence).
This document discusses a capstone project on the level of integration between health and medical device data with clinical systems. It covers topics like current healthcare information systems, quality monitoring and accreditation, and legal/ethical issues. The document also discusses the importance of understanding the systems used in healthcare work, keeping up with regulations, and addressing how health/medical devices and data will integrate with information systems and respect patient privacy. Tables show patient preferences between electronic vs paper logs for managing diabetes information. References at the end provide additional resources on HIPAA compliance, treatment options, and healthcare information.
The document discusses the CDC's LabHIT program which aims to facilitate laboratory test ordering and reporting in electronic health records. The program develops and disseminates standardized terminology and code sets to support clinical data capture and interoperability. It also works with various stakeholders to engage in terminology development, promote semantic interoperability, and ensure usability and patient safety. The long-term goal is a single national reference database for recommended vocabulary sets to achieve full-scale interoperability for laboratory data.
New ALERT - Factors on quality pediatric care by paramedics using In-Situ Sim...INSPIRE_Network
This document summarizes a proposed study to evaluate factors associated with high quality pediatric care by paramedics using in-situ simulation. The study would involve paramedics from Northeast and Midatlantic states participating in simulations of 3 standardized pediatric cases using validated checklists and video review. The objectives are to identify factors associated with high quality pre-hospital pediatric care and areas of training that could be improved. The proposed timeline includes IRB submission in 2 months, starting data collection in 6 months, completing data analysis and manuscript in 12 months.
New ALERT - Improving Pediatric Acute Care in Community EDs through Collabora...INSPIRE_Network
This document proposes a study to compare the effectiveness of a modular pediatric resuscitation improvement program (PRIP) to a pediatric care coordinator (PECC) alone at improving pediatric resuscitation quality in community emergency departments. The study would involve cluster randomization of EDs to either receive the PRIP intervention or act as controls with a PECC. Outcomes would include composite quality scores measured through in-situ simulations, chart review scores, and pediatric readiness survey scores. The goal is to develop and test a low-cost PRIP to help PECCs improve pediatric emergency care.
Natasha Amaro completed a six-hour course on Good Clinical Practices through the NIDA Clinical Trials Network, passing modules on institutional review boards, informed consent, confidentiality and privacy, participant safety and adverse events, quality assurance, the research protocol, documentation and record-keeping, research misconduct, roles and responsibilities, recruitment and retention, and investigational new drugs. She received a certificate of completion dated March 3, 2016 that is valid through March 3, 2019.
This document provides an overview of evidence-based medicine resources for pediatrics. It defines evidence-based medicine and discusses the importance of both clinical expertise and best external evidence. It then lists various computer systems, journals, and the Cochrane Library that can help find evidence. It explains how to formulate clinical questions using the PICO framework and identifies the best study designs to answer different types of clinical questions. An example clinical question is provided. Finally, it lists several websites that provide evidence-based care guidelines, journal reviews, and other pediatric EBM resources.
This document discusses continuing review requirements for research studies and outlines plans to improve the process. It notes that studies must undergo continuing review at least annually. Metrics will be used to measure progress, including tracking studies that lapse in approval and ensuring new enrollment information is updated in a timely manner for continuing review submissions. Challenges include ensuring all relevant study information is compiled and discussed among the research team for continuing review. The plan is to address key areas in the clinical research application and have important regulatory conversations in working group meetings.
This document discusses access challenges for orphan drugs and specialized therapies in Canada. It proposes alternative models like managed access programs and adaptive listings to generate real-world evidence for these treatments. Managed access programs in other countries tie reimbursement to ongoing data collection on safety, effectiveness and appropriate use. Challenges include defining patient eligibility, setting stopping criteria, and assigning stakeholder roles. The document also describes private insurers' initiatives in Canada like chronic disease management programs and references to CADTH reviews. It argues collaborative solutions are needed to provide timely, equitable access to promising rare disease therapies in a sustainable way.
Health Datapalooza IV: June 3rd-4th, 2013
Datalab
Moderator:
Todd Park, Chief Technology Officer, United States
Damon Davis, Health Data Initiative Program Director, Department of Health and Human Services
Speakers:
Susan Queen, Director, Division of Data Policy, Office of the Assistant Secretary for Planning and Evaluation
Steve Cohen, Director, Center for Financing, Access and Cost Trends, Agency for Healthcare Research & Quality
Rick Moser, National Institutes of Health
Victor Lazzaro, Performance & Data Analytics Manager, Office of the National Coordinator for Health IT
Niall Brennan, Director of the Office of Information Products and Data Analytics, Center for Medicare and Medicaid Services
Miya Cain, Office of the Assistant Secretary, Administration for Children and Families, US Department of Health and Human Services
Edward Salsberg, Director, National Center for Health Workforce Analysis, Health Resources and Services Administration
Robert Post, Environmental Protection Agency (EPA)
Eugene Hayes, the Substance Abuse and Mental Health Services Administration (SAMHSA)
Jim Craver, Center for Disease Control and Prevention (CDC)
David Forrest, Senior Advisor, Health and Human Services Office of the Chief Technology Officer
Tania Allard, Director of Intergovernmental Affairs & Special Projects, New York State Department of Health
Steven Edwards, Environmental Protection Agency
Steve Emrick, National Library of Medicine
Carol A. Gotway Crawford, Director of Behavioral Surveillance, Centers for Disease Control
This perennial favorite breakout session is back! This is the best opportunity to meet some of the federal government data experts who champion action in improving public access to information to catalyze innovation. Come learn how to use assets from the Department of Health & Human Services (HHS), the Department of Agriculture (USDA), the Environmental Protection Agency (EPA) and more. Each agency in the federal government is staffed by experts who are well versed in the information resources available from their division on data.gov (administrative data, survey data, research data, medical/scientific content, etc.) The Datalab will also feature opportunities for one-on-one meet-ups with data experts for “deep dives” into agency’s resources. Participants can join live demonstrations and check out new data resources and tools. The goal of the session is to give innovators and entrepreneurs an overview of new, updated, and emerging datasets that can be used to support new applications and services.
Telemedicine allows for remote monitoring and consultation of ICU patients using technology. It has historical roots in addressing gaps in intensivist coverage. Key terms include telemedicine, tele-physician, and tele-nurse. Current applications include ICU consultations, monitoring patients with conditions like CHF, and providing care to remote or underserved populations. Telemedicine monitoring involves teams of tele-nurses and physicians overseeing multiple ICU beds using virtual patient records and monitoring equipment. Studies show benefits to patient outcomes and safety, though some clinicians note potential disadvantages like loss of bedside experience.
UCSF Cores Search 2.0: Design Strategy OverviewCTSI at UCSF
Learn more about Anirvan Chatterjee's work: http://profiles.ucsf.edu/ProfileDetails.aspx?From=SE&Person=5396511
Learn more about Brian Turner's work: http://profiles.ucsf.edu/ProfileDetails.aspx?From=SE&Person=5333232
Building Your Professional Network with LinkedInCTSI at UCSF
Presentation by Erik Wieland, Applications Manager at UCSF IT, as part of the "UCSF Profiles & LinkedIn Bootcamp for Researchers, Faculty, Staff" on 2/9/2015.
Primary care-based, teleretinal-screening protocol (Los Angeles Safety Net) UCLA CTSI
UCLA CTSI-Los Angeles County Department of Health Services (DHS) Projects
Principal Investigators: Lauren Daskivich (DHS), Carol Mangione (UCLA)
Diabetic retinopathy (DR) is the leading cause of blindness among working-age Americans, and among Los Angeles Latinos—the ethnic majority of patients in the Los Angeles County (LAC) safety net—the prevalence of DR is ~50%. Despite evidence that early detection and treatment can prevent blindness from DR, a significant number of persons with diabetes in our system fail to receive annual screening examinations and/or sight-saving treatments due to lack of access to specialty care. To date, the effect of a system level intervention on improving access to eye care and definitive treatment for diabetic retinopathy in an urban medically underserved, or safety net, population has not been evaluated. The objective of this project is to evaluate the impact of teleretinal screening on access to specialty ophthalmic care for diabetic patients in LAC who need monitoring or treatment for diabetic retinopathy. We propose a pre-post analysis of the LAC teleretinal screening implementation, and we aim to evaluate the number of patients screened for diabetic retinopathy, the number presenting for timely ophthalmic follow-up care and treatment, and the cost of the program.
This document discusses the development of a chronic disease diagnosis (CDD) system using large datasets to predict disease risk and provide medical advice recommendations. Currently, a hybrid CDD method uses multiple classification algorithms and collaborative filtering to build an accurate predictive model. Testing of the CDD system is being done using Middle Eastern data and future work involves further testing using diabetes case studies to improve accuracy and feasibility of recommendations.
SITIST 2015 Dev - Turning big data into presicion medicine real life examplessitist
Big data in healthcare comes from a variety of sources and formats including clinical trials, patient records, medical literature, genomic data, and medical imaging. This large volume of data presents challenges to make it accessible and usable. SAP offers platforms and solutions to unlock the value in healthcare big data by enabling precision medicine through analyzing diverse clinical and genomic data sources. Examples include SAP's partnership with ASCO on the CancerLinQ project to link oncology data and improve cancer treatment, and SAP Medical Research Insights deployed at the National Center for Tumor Diseases in Heidelberg, Germany.
This document discusses an integrated clinical engagement model for personal health records (PHRs). It describes key drivers for this model including efforts to increase efficiency, wellness, medical management, and consumer experience. The model includes a clinical data repository that integrates various types of patient data. Challenges include a lack of standards for transferring all types of PHR data between health plans and representing elements such as alerts and physiological information. Alignment with existing standards and expanding PHR data domains are suggested for moving forward.
Information technology, Transformational change - Stories from the road. Presented by Robyn Cook, IT Project Manager, University of New South Wales, Australia, at HINZ 2014, 12 November 2014, 1.45pm, Marlborough Room
This document discusses strategies for improving timely access to healthcare services in Alberta, Canada. It proposes standardizing referral processes, automating referral tracking, and using clinical decision support tools. An online referral system called Netcare has launched for several specialties, with mixed results. Next steps include continued support and evaluation of the system with the goal of broader adoption and improved wait times.
A project with the aim to standardize an RBM approach in clinical trials. It unites four companies and academic organizations, focuses on the evaluation and optimization of Risk-based Monitoring (RbM). For this purpose, PUEKS will use data available from past clinical studies to select substantiated key risk indicators (KRIs). Subsequently, the obtained data-driven KRIs will be tested in an ongoing trial. A comparative evaluation with historical data from past studies will be additionally performed to evaluate the power of the selected KRIs in terms of cost savings, enhanced quality, and risk mitigation. The project is aimed at delivering a robust RbM tool as well as an optimized procedure for the successful implementation of RbM.
This project (HA project no. 448/14-38) is funded in the framework of Hessen ModellProjekte, financed with funds of LOEWE – Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Förderlinie 3: KMU-Verbundvorhaben (State Offensive for the Development of Scientific and Economic Excellence).
This document discusses a capstone project on the level of integration between health and medical device data with clinical systems. It covers topics like current healthcare information systems, quality monitoring and accreditation, and legal/ethical issues. The document also discusses the importance of understanding the systems used in healthcare work, keeping up with regulations, and addressing how health/medical devices and data will integrate with information systems and respect patient privacy. Tables show patient preferences between electronic vs paper logs for managing diabetes information. References at the end provide additional resources on HIPAA compliance, treatment options, and healthcare information.
The document discusses the CDC's LabHIT program which aims to facilitate laboratory test ordering and reporting in electronic health records. The program develops and disseminates standardized terminology and code sets to support clinical data capture and interoperability. It also works with various stakeholders to engage in terminology development, promote semantic interoperability, and ensure usability and patient safety. The long-term goal is a single national reference database for recommended vocabulary sets to achieve full-scale interoperability for laboratory data.
New ALERT - Factors on quality pediatric care by paramedics using In-Situ Sim...INSPIRE_Network
This document summarizes a proposed study to evaluate factors associated with high quality pediatric care by paramedics using in-situ simulation. The study would involve paramedics from Northeast and Midatlantic states participating in simulations of 3 standardized pediatric cases using validated checklists and video review. The objectives are to identify factors associated with high quality pre-hospital pediatric care and areas of training that could be improved. The proposed timeline includes IRB submission in 2 months, starting data collection in 6 months, completing data analysis and manuscript in 12 months.
New ALERT - Improving Pediatric Acute Care in Community EDs through Collabora...INSPIRE_Network
This document proposes a study to compare the effectiveness of a modular pediatric resuscitation improvement program (PRIP) to a pediatric care coordinator (PECC) alone at improving pediatric resuscitation quality in community emergency departments. The study would involve cluster randomization of EDs to either receive the PRIP intervention or act as controls with a PECC. Outcomes would include composite quality scores measured through in-situ simulations, chart review scores, and pediatric readiness survey scores. The goal is to develop and test a low-cost PRIP to help PECCs improve pediatric emergency care.
Natasha Amaro completed a six-hour course on Good Clinical Practices through the NIDA Clinical Trials Network, passing modules on institutional review boards, informed consent, confidentiality and privacy, participant safety and adverse events, quality assurance, the research protocol, documentation and record-keeping, research misconduct, roles and responsibilities, recruitment and retention, and investigational new drugs. She received a certificate of completion dated March 3, 2016 that is valid through March 3, 2019.
This document provides an overview of evidence-based medicine resources for pediatrics. It defines evidence-based medicine and discusses the importance of both clinical expertise and best external evidence. It then lists various computer systems, journals, and the Cochrane Library that can help find evidence. It explains how to formulate clinical questions using the PICO framework and identifies the best study designs to answer different types of clinical questions. An example clinical question is provided. Finally, it lists several websites that provide evidence-based care guidelines, journal reviews, and other pediatric EBM resources.
This document discusses continuing review requirements for research studies and outlines plans to improve the process. It notes that studies must undergo continuing review at least annually. Metrics will be used to measure progress, including tracking studies that lapse in approval and ensuring new enrollment information is updated in a timely manner for continuing review submissions. Challenges include ensuring all relevant study information is compiled and discussed among the research team for continuing review. The plan is to address key areas in the clinical research application and have important regulatory conversations in working group meetings.
This document discusses access challenges for orphan drugs and specialized therapies in Canada. It proposes alternative models like managed access programs and adaptive listings to generate real-world evidence for these treatments. Managed access programs in other countries tie reimbursement to ongoing data collection on safety, effectiveness and appropriate use. Challenges include defining patient eligibility, setting stopping criteria, and assigning stakeholder roles. The document also describes private insurers' initiatives in Canada like chronic disease management programs and references to CADTH reviews. It argues collaborative solutions are needed to provide timely, equitable access to promising rare disease therapies in a sustainable way.
Health Datapalooza IV: June 3rd-4th, 2013
Datalab
Moderator:
Todd Park, Chief Technology Officer, United States
Damon Davis, Health Data Initiative Program Director, Department of Health and Human Services
Speakers:
Susan Queen, Director, Division of Data Policy, Office of the Assistant Secretary for Planning and Evaluation
Steve Cohen, Director, Center for Financing, Access and Cost Trends, Agency for Healthcare Research & Quality
Rick Moser, National Institutes of Health
Victor Lazzaro, Performance & Data Analytics Manager, Office of the National Coordinator for Health IT
Niall Brennan, Director of the Office of Information Products and Data Analytics, Center for Medicare and Medicaid Services
Miya Cain, Office of the Assistant Secretary, Administration for Children and Families, US Department of Health and Human Services
Edward Salsberg, Director, National Center for Health Workforce Analysis, Health Resources and Services Administration
Robert Post, Environmental Protection Agency (EPA)
Eugene Hayes, the Substance Abuse and Mental Health Services Administration (SAMHSA)
Jim Craver, Center for Disease Control and Prevention (CDC)
David Forrest, Senior Advisor, Health and Human Services Office of the Chief Technology Officer
Tania Allard, Director of Intergovernmental Affairs & Special Projects, New York State Department of Health
Steven Edwards, Environmental Protection Agency
Steve Emrick, National Library of Medicine
Carol A. Gotway Crawford, Director of Behavioral Surveillance, Centers for Disease Control
This perennial favorite breakout session is back! This is the best opportunity to meet some of the federal government data experts who champion action in improving public access to information to catalyze innovation. Come learn how to use assets from the Department of Health & Human Services (HHS), the Department of Agriculture (USDA), the Environmental Protection Agency (EPA) and more. Each agency in the federal government is staffed by experts who are well versed in the information resources available from their division on data.gov (administrative data, survey data, research data, medical/scientific content, etc.) The Datalab will also feature opportunities for one-on-one meet-ups with data experts for “deep dives” into agency’s resources. Participants can join live demonstrations and check out new data resources and tools. The goal of the session is to give innovators and entrepreneurs an overview of new, updated, and emerging datasets that can be used to support new applications and services.
Telemedicine allows for remote monitoring and consultation of ICU patients using technology. It has historical roots in addressing gaps in intensivist coverage. Key terms include telemedicine, tele-physician, and tele-nurse. Current applications include ICU consultations, monitoring patients with conditions like CHF, and providing care to remote or underserved populations. Telemedicine monitoring involves teams of tele-nurses and physicians overseeing multiple ICU beds using virtual patient records and monitoring equipment. Studies show benefits to patient outcomes and safety, though some clinicians note potential disadvantages like loss of bedside experience.
UCSF Cores Search 2.0: Design Strategy OverviewCTSI at UCSF
Learn more about Anirvan Chatterjee's work: http://profiles.ucsf.edu/ProfileDetails.aspx?From=SE&Person=5396511
Learn more about Brian Turner's work: http://profiles.ucsf.edu/ProfileDetails.aspx?From=SE&Person=5333232
Building Your Professional Network with LinkedInCTSI at UCSF
Presentation by Erik Wieland, Applications Manager at UCSF IT, as part of the "UCSF Profiles & LinkedIn Bootcamp for Researchers, Faculty, Staff" on 2/9/2015.
The document discusses the San Francisco Health Improvement Partnership (SF HIP) initiative, which is a collaboration between UCSF, San Francisco government agencies, community clinics, schools, and community organizations. The goal of SF HIP is to use research from UCSF to improve population health in San Francisco and reduce health disparities. SF HIP focuses on priority health issues like physical activity, hepatitis B, alcohol, and mental health. For each issue, partnerships identify target populations, desired outcomes, interventions, and metrics to evaluate the interventions. Examples provided include a project using data to identify high users of multiple services related to alcohol and a quality improvement collaborative around hepatitis B care.
UCSF International Research and the Connection to the HIV CommunityCTSI at UCSF
UCSF conducts extensive international HIV research. [1] Over 200 faculty conduct research in over 100 countries, with over $77 million in awards. [2] Coordination efforts include the AIDS Research Institute and Center for AIDS Research. [3] More coordination is needed across departments and standardization of practices. [4] Early antiretroviral therapy reduces HIV transmission and provides individual health benefits, though challenges remain in implementation.
The document summarizes the UC Research eXchange (UC-ReX) program, which aims to improve collaborative research across University of California campuses by enhancing access to clinical data. Key points:
- UC-ReX was initiated in 2011-2012 with initial funding to advance UC collaborative research capabilities.
- Its goals for Year 1 were to enable cross-campus cohort identification by developing governance, selecting a technical infrastructure, harmonizing data, and enabling access/support.
- The Year 1 budget outlined costs for management, technology strategy, implementation, data alignment, and support workgroups totaling over $1 million.
- An executive committee with members from multiple UC campuses governs UC
UCSF CER - Intro to Stakeholder-Engaged Research (Symposium 2013)CTSI at UCSF
This document provides an introduction to stakeholder-engaged research. It discusses promoting outcomes that are important to patients, ensuring stakeholders have relevant information to make medical decisions, and getting all stakeholders working toward common goals. It notes initiatives like the NIH Roadmap and Affordable Care Act that promote stakeholder engagement. It identifies interested organizations like PCORI, AHRQ, CMS Innovation Center, and foundations. It outlines funding opportunities for stakeholder-engaged research through these organizations, totaling billions of dollars through 2019.
The document discusses the 2012 annual retreat of the Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco. It notes that over 260 people attended the retreat, including many campus leaders and panelists. The retreat had a fun agenda aimed at helping CTSI continue its trajectory. It also discusses key questions around how CTSI knows it is meeting its mission and how it can better serve its "customers". CTSI faces drivers for change like reduced funding but aims to preserve its core mission overseen by NCATS.
UCSF Participant Recruitment Service: Preparing for Launch!CTSI at UCSF
The Participant Recruitment Service at UCSF is preparing for launch with a soft launch phase involving developing recruitment materials, piloting recruitment services for 4 studies, creating a participant registry database, and conducting passive recruitment from the Integrated Data Repository database. The PRS aims to centralize recruitment efforts and address challenges like limited coordinator time, uncoordinated multi-site efforts, and lack of diversity in clinical trials. The soft launch will test recruitment materials, registry, and services to help enroll more research participants.
Best Practices in Clinical Study RecruitmentCTSI at UCSF
This document discusses best practices in clinical study recruitment and retention. It covers:
1) Recruitment practices such as performing initial analyses of study design and site-specific factors, planning and budgeting for screen failures and protocol changes, and implementing a staged communication plan.
2) Retention practices like ensuring participants are well-informed, understanding their needs, and keeping communication open.
3) A proposed Participant Recruitment Service at UCSF to centralize recruitment efforts through activities like recruitment analysis, direct mailings to patient cohorts, and developing recruitment materials and resources.
This document discusses secondary data analysis and provides examples of large federal health surveys that can be used for secondary analysis, including NHANES and NHIS. It outlines strengths and limitations of secondary data analysis. Complex survey design must be accounted for, including statistical weighting, clustering, and stratification. Several statistical software programs are designed for analyzing complex survey data. The document concludes with a hypothetical case study using NHIS and EPA air pollution exposure data to study the relationship between acrolein levels and childhood asthma episodes.
Clinical trials are necessary for medical research. Producing new medicines to the market depends on the strength of research organizations and drug companies to test and verify their work vigorously through their Clinical Trials, but finding people willing to participate is notoriously tricky.
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
Technology is slowly but surely penetrating the healthcare industry in general and the clinical trials sector in particular. New and advanced solutions offer a variety of possibilities aimed to both improving existing processes and creating new and more efficient ones. And on top of all stands the desire to make clinical trials more patient centric.
In all of this, even though some of the technologies have yet to mature enough to meet the high quality standards necessary, it is important to know them and begin imagining the promise they hold for clinical trials.
Global Clinical Trials: Best Practices & Common PitfallsImperial CRS
This document discusses best practices and common pitfalls to avoid when planning and conducting global clinical trials. It identifies key factors to consider such as study feasibility, regulatory requirements, site selection, and patient recruitment. Specific pitfalls addressed include unrealistic protocol design, poor planning, incomplete feasibility data, lack of customized recruitment strategies, and inadequate consideration of local regulatory, cultural and logistical factors. The importance of leveraging local expertise and collecting metrics to guide a data-driven approach is emphasized. A case study example illustrates how challenges can reshape a study's scope and timeline.
Solving the operational challenges of oncology clinical trialsRoberto Lara
This executive briefing explores new strategies for solving your oncology clinical operations challenges. It also features valuable insights into how you can enrich your site selection, speed up your start-up times and maximize patient recruitment opportunities here in North America.
The document discusses the development and findings of a pilot Electronic Care Record (ECR) project in Northern Ireland. The key points are:
1) The pilot integrated clinical information from 16 existing health systems and allowed clinicians to access patient data via a single login.
2) Evaluation found the ECR improved clinical outcomes and decision making. 97% of users were satisfied with ease of use and found it useful.
3) The pilot demonstrated that a regional ECR is achievable and could help improve patient safety, quality of care and reduce costs across Northern Ireland.
Preliminary results from a survey on the use of metrics and evaluation strate...jehill3
Preliminary results from a survey on the use of metrics and evaluation strategies among mHealth projects
Patricia Mechael, Nadi Kaonga
Center for Global Health and Economic Development at the Earth Institute, Columbia University
CORE Group Spring Meeting, April 30, 2010
- Patient recruitment for clinical trials is a major challenge, estimated to be a $1.2-1.8 billion market. Recruitment costs average 6% of trial costs and are a primary factor in delays.
- Less than 5% of patients are aware of clinical trials, and only 2-3% actually enroll. However, over 90% of participants have a positive experience and would participate again.
- There is significant opportunity to improve recruitment through more patient-centric approaches leveraging data, technology, and analytics to identify more eligible patients and improve the recruitment process. However, this will require changes to traditional models.
Top 5 Warning Signs Your Clinical Trial Is Off TrackDavid Levin
This document discusses risk management in clinical trials. It outlines a four-step process for risk management: risk assessment and analysis, risk mitigation, risk measurement, and risk management. It provides examples of early warning signs to look for during study start-up and operations, how to measure those risks, and how to address risks that become issues. Some potential risks discussed include slower than expected enrollment, poor site compliance, and breakdown of sponsor-CRO relationships.
The document discusses strategies for developing a reimbursement case for molecular diagnostic tests early in development. It emphasizes designing analytic and clinical validity studies to demonstrate test accuracy and association with clinical conditions. Clinical utility studies should show how test results impact patient management, outcomes, and healthcare costs. Randomized controlled trials provide the strongest evidence but alternative study designs like prospective observational studies and decision modeling may also support reimbursement. The goal is to generate evidence of a test's medical necessity and value to payers from an early stage.
Developing the Reimbursement Story 2016-03-10Lyssa Friedman
The document discusses strategies for developing a reimbursement case for molecular diagnostic tests early in development. It emphasizes designing analytic and clinical validity studies to demonstrate test accuracy and association with clinical conditions. Clinical utility studies should show how test results impact patient management, outcomes, and healthcare costs. Randomized controlled trials provide the strongest evidence but alternative study designs like prospective observational studies and decision modeling may also support reimbursement. The goal is to generate evidence of a test's medical necessity from the intended patient population to achieve coverage and payment.
Tools to Drive Enrollment OCT Arena-Boston-2015Dan Diaz
The 4th Annual Clinical Operations in Oncology Trials East Coast was an amazing hit. Over 25 speakers challenged the 200 attendees on how- "WE" as an industry can use new tools and strategies to better our Clinical Trial Execution and Patient Enrollment.
With only 3% of the patients in the USA participating in Cancer Trials- we have to do a better job finding ways to educate them about the benefits of clinical studies.
The following tools are some of the new enhancements for better site and physician selection which can help find better results.
How To Optimize Your EDC Solution For Risk Based Monitoringwww.datatrak.com
This presentation presents best training practices to leverage EDC technology and risk-based monitoring to effectively and efficiently monitor clinical research.
Our focus is on the practical process of preparing your team to optimize the tools made available through an EDC solution.
This presentation is applicable to CRA’s, clinical project managers, clinical data managers, regulatory compliance professionals, and those involved in the design and implementation of risked-based monitoring plans.
Clinical research informatics involves using informatics tools to support clinical research activities like managing clinical trials data and conducting secondary research using clinical data. It can help make clinical trials more efficient by facilitating study design, subject recruitment from electronic medical records and social media, data collection and management, and data analysis. National initiatives aim to develop informatics tools and networks to help researchers access data and accelerate clinical research.
Cognika's Trial XL uses machine learning to analyze clinical trial data and provide insights to improve trial operations. It profiles investigators and sites, evaluates criteria that impact recruitment and outcomes, and ranks investigators. Case studies showed it identified criteria impacting recruitment, better accrual estimates, and new investigators, helping reduce delays. Trial XL leverages all past learning, applies analytics to extract insights, and accelerates decision making for clinical trials.
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceCognizant
To address draft regulatory guidance for risk-based clinical trial monitoring, sponsors should consider strategies that utilize social, mobile, analytics and cloud technologies to create responsive methodologies that satisfy both the spirit and the letter of these new guidelines.
This funding allowed Sentara Healthcare to take a systems approach to implementing NHSN surgical site infection (SSI) surveillance. They used $124,000 for information technology assistance to develop an electronic process for exporting surgical procedure data directly into NHSN. They also used $21,000 to train infection prevention and control staff as well as data auditors on SSI surveillance. This funding demonstrated how a large healthcare system can collaborate across departments like IT, infection prevention, and data auditors to efficiently implement NHSN reporting requirements.
Intelligent Clinical Supply Forecasting and Simulations through IRT-March02-2...Praveen Chand
This document discusses using intelligent clinical supply forecasting and simulations through an interactive response technology (IRT) system. It highlights trends and challenges in clinical trials that increase pressure on sponsors and CROs. Simulation and forecasting tools that integrate with an IRT system can help optimize drug supply planning, reduce costs from overages, and improve efficiency. Real-time data from the IRT on enrollments, visits, and inventory levels allows frequent reforecasting to reduce supply chain risks and costs. The presentation provides an overview of how analytics and simulations using IRT data can help various stakeholders with challenges around forecasting demand, optimizing distribution, and efficient planning of drug supplies.
Similar to A Less Focused Approach to Increasing the Pool of Research Participants: All Volunteers All the Time (20)
AMIA Joint Summits 2017: Building Research Data Mart from UCSF OMOP Database ...CTSI at UCSF
This document outlines a project to build a clinical data mart from an institutional OMOP database for a kidney transplant registry study. The project team extracted relevant data from an Epic EMR database, transformed it to OMOP common data model, and loaded it into a research data mart. They provided ongoing access to transplant patient data, learned about building customized data products, and identified reusable components. User involvement in testing validated the data quality for research use.
The document discusses new initiatives at the Patient-Centered Outcomes Research Institute (PCORI) related to pragmatic clinical studies and engagement. Key points include:
- PCORI is emphasizing large pragmatic clinical studies to compare medical interventions and engage patients and other stakeholders throughout the research process.
- New areas of focus include establishing study advisory committees involving stakeholders, engaging medical societies in research, and funding the dissemination of study results.
- PCORI is prioritizing research topics nominated by patients and other stakeholders and conducting targeted funding opportunities on focused clinical questions.
The document provides information about the Pediatric IntraVenous Versus Oral antibiotic Therapy (PIVVOT) study, which will compare the effectiveness of oral antibiotics versus intravenous antibiotics delivered via a PICC line in children requiring prolonged home antibiotic therapy. The study is a retrospective cohort study involving chart reviews at 36 participating children's hospitals. It is led by researchers from the Children's Hospital of Philadelphia and the Pediatric Research in Inpatient Settings Network. The document outlines the study aims, methods, personnel, and plans for institutional review board approval and data collection across sites.
CER 2016 Phillips cer symposium pcori 2016 from 012716CTSI at UCSF
This document discusses the development of PCORI's research agenda on personalized and precision medicine. It outlines Kathryn Phillips' role as an advisor to PCORI on this topic. Specifically, it describes efforts to develop targeted funding opportunities through PCORI that address key issues within personalized medicine while adhering to PCORI's mandate of comparative effectiveness research. This includes conducting expert interviews and stakeholder meetings to inform the development of research funding announcements focused on direct comparisons of personalized medicine approaches in real-world settings.
CER 2016 Nguyen ctsi collaborative researchCTSI at UCSF
This document describes the Health Within Reach project, a collaborative effort between UCSF, SFGH, and SF Hep B Free to improve hepatitis B and C screening for Asian Americans. The team was formed due to their shared focus on Asian American health disparities and complementary expertise in clinical research, community engagement, and multi-lingual interventions. Challenges in collaborating across organizations were addressed through regular communication, consensus decision-making, and flexibility. The project aims to develop and evaluate a video and provider alert intervention to increase screening rates.
This document discusses engaging patients in clinical research. It notes that currently many clinical practice guidelines have low levels of evidence due to gaps in research evidence. Involving patients throughout the research process from designing studies to disseminating results can help address these gaps. The document outlines various roles patients can play at each stage of research, from providing input on study design to assisting with study recruitment and monitoring studies. It also discusses challenges like making protocols feasible for patients. The PROSPER study is highlighted as an example of patient-centered research that addresses outcomes important to patients. The conclusion emphasizes that patients will continue driving improvements in care and should be meaningfully engaged in the research process.
This document discusses a project called EQUIP that aims to develop new methods for analyzing and displaying qualitative data in patient-centered outcomes research (PCOR). The project will draw on existing studies involving over 200 cancer patients to develop tools for extracting narratives from illness experiences. An "ethnoarray" approach is proposed to visually array patients' narratives based on domains like treatment decisions and social support. The goals are to engage stakeholders like researchers, providers, and patients to establish standards for using qualitative data in PCOR and assess new methods' feasibility in clinical practice. Challenges include bridging different disciplinary approaches, but the project sees opportunities to innovate at the intersection of qualitative and quantitative health research methods.
CER 2016 Jacoby stakeholder engagementCTSI at UCSF
This document discusses stakeholder engagement in patient-centered outcomes research. It begins by explaining the change from a researcher-centered model to including stakeholders. Key stakeholders are identified as patients, providers, drug/device companies, insurers, and advocates. Stakeholder engagement is required by PCORI to support funding, improve enrollment, strengthen research design, and broaden impact. Examples are provided of how a study on uterine fibroid treatment engaged stakeholders in design, recruitment, and dissemination of results. Challenges and new approaches like crowdsourcing input are also discussed.
Data Reproducibility in Preclinical Discovery, Is It a Real Problem? 09/17/15CTSI at UCSF
On Sep 17th Catalyst brought a panel of academic and industry thought leaders for a lively discussion on the issue of data reproducibility in academic research. Moderated by Cathy Tralau-Stewart, head of the Therapeutics track of the Catalyst Awards, the panel explored causes and potential solutions for a problem that has been receiving national attention in both scientific and popular media.
Panelists included Keith Yamamoto, Vice Chancellor for Research at UCSF; Larry Tabak, Principle Deputy Director, NIH; John Ioannidis, Professor of Health Research Policy at Stanford School of Medicine; Elizabeth Iorns, Co-Founder, Science Exchange; Parker B. Antin, Board of Directors President, FASEB; Amanda Halford, MBA, VP of Research, Sigma-Aldrich.
http://ctsi.ucsf.edu/news/about-ctsi/data-reproducibility-preclinical-research-and-discovery
How to Harness the Power of Google Analytics, Email Marketing & Vanity to Inc...CTSI at UCSF
40 minute presentation by Nooshin Latour (@nooshin) & Anirvan Chatterjee (@anirvan) at the UC Computing Services Conference (UCCSC 2014). Evolution of UCSF Profiles research networking system, early promotion at launch, growth/SEO, and engagement with targeted personalized data emails. Full description here: https://uccsc.ucsf.edu/node/101
VIVO 2014: Google Analytics, Email Marketing & Vanity to Increase User Engage...CTSI at UCSF
Poster presented at VIVO 2014 conference: Utilized UCSF Profiles web analytics data to deliver a customized “UCSF Profiles Annual Report” to individual researchers at UCSF, which listed their total annual unique pageviews, broken down by major relevant categories (e.g. pageviews from the UCSF campus, NIH, pharmaceutical companies, foundations, and other universities). Result: Increase in user engagement and edite Profiles pages. UCSF-CTSI Team: Nooshin Latour, MA, Sr. Communications & Marketing Manager and Anirvan Chatterjee, Director of Data Strategy
UCSF Informatics Day 2014 - Mark Pletcher, "Making EHR Data Useful for the Le...CTSI at UCSF
This document discusses turning UCSF into a Learning Healthcare System by using electronic health record (EHR) data to continuously improve patient care and conduct research. There are barriers like mixing research with clinical care and EHRs not being designed for research. The document proposes starting small projects like randomized quality improvement trials to test interventions, and building infrastructure to support larger comparative effectiveness research networks. Ethical issues around informed consent for randomized projects are also discussed. The goal is to leverage EHR data and engaged patients to efficiently conduct research that enhances care.
UCSF Informatics Day 2014 - Ida Sim, "Informatics Technologies: From a Data-C...CTSI at UCSF
This document discusses moving from a data-centric to a hypothesis-centric view of clinical and translational research using electronic health records and other informatics technologies. It notes that most current research is observational rather than interventional, and outlines ways informatics could better support hypothesis testing through virtual, community-based, and point-of-care clinical trials by integrating risk calculators, structured note templates, surveys, and other tools directly into clinical workflows and patient portals. The presentation calls for further developing these informatics capabilities to facilitate more interventional research at lower cost.
UCSF Informatics Day 2014 - Keith R. Yamamoto, "Precision Medicine"CTSI at UCSF
Keith R. Yamamoto, PhD — Opening Remarks – Precision Medicine
Vice Chancellor for Research
Executive Vice Dean of the School of Medicine
Professor of Cellular and Molecular Pharmacology
UCSF
UCSF Informatics Day 2014 - Jocel Dumlao, "REDCap / MyResearch"CTSI at UCSF
This document provides an overview of MyResearch and REDCap systems at UCSF. MyResearch is a data hosting service that provides a secure, HIPAA-compliant environment for storage and management of research data. It offers tools like a virtual desktop, shared drives, and data analysis software. REDCap is a web-based tool for building surveys and electronic data capture forms. It offers features like auto-validation, file uploads, and export to analysis packages. Both systems provide training through online and in-person sessions.
UCSF Informatics Day 2014 - Lindsey Watt Alami, "Study Management throughout ...CTSI at UCSF
OnCore is a comprehensive clinical research data capture and management system used at UCSF and its affiliates. It includes modules for clinical research management, unified registry management, biospecimen management, and other functions. OnCore supports the entire clinical trial lifecycle from study startup through ongoing management and post-award activities. It facilitates collaboration between research teams and provides tools to track important study events and metrics for regulatory approvals, subject visits, data collection, and billing compliance. The goal is to integrate OnCore further with other systems at UCSF like iRIS and APeX to streamline clinical research processes.
UCSF Informatics Day 2014 - Elizabeth St. Lezin, "Blood Transfusion Research ...CTSI at UCSF
The NHLBI REDS-III program uses electronic health record databases to conduct transfusion medicine research. REDS-III collects donor, blood product, and recipient data from multiple hospitals and blood centers in the US and abroad. This document outlines REDS-III's research goals, institutional infrastructure, data flow process, and planned studies including evaluating transfusion outcomes in elderly patients, severe transfusion reactions, and genetic factors influencing red blood cell storage capacity. A pilot matched donor, product, and recipient data from one hospital to demonstrate REDS-III's database approach for conducting epidemiological analyses and identifying predictors of transfusion.
UCSF Informatics Day 2014 - Dana Ludwig, "Research Data Browser"CTSI at UCSF
The document summarizes the Research Data Browser, a tool that enables UCSF investigators to rapidly query de-identified clinical data to generate hypotheses and profile selected patients. It allows visualizing data through different views and tabs, applying filters, and exporting results. Access requires submitting a request through the Account Request Form system. Some limitations include only including data after June 2012 and orders being limited. Feedback is encouraged to improve the tool and data.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
10. Recruitment Trends by County UCSF Airway Clinical Research Center (ACRC) San Francisco 52% Alameda 16% San Mateo 11% Contra Costa 7% Santa Clara 4% Marin 3% Sonoma 2% Solano 1%
11. Age by Method of Contact UCSF Airway Clinical Research Center (ACRC)
Clinic patients – relying on the population who already is identified is fine but you must be realistic about how many of those will actually be interested, show up, meet remaining criteria, and enroll. Advertising to study demographics means spending lots of $$ for minimal return
Referral networks – making strong, long-term partners of fewer referring practices, collaborative research networks, using navigators